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Treatment of Chronic Facial Erythema of Dermatomyositis with 
Intense Pulsed Light Therapy
Dermatomyositis is an idiopathic inflammatory myopathy that may 
include persistent facial erythema, which is refractory to topical and 
systemic treatments. In previous reports a pulsed dye laser was effective 
in the treatment of these skin lesions. We report the first case of the use 
of intense pulsed light therapy for treatment of cutaneous lesions in 
dermatomyositis, which showed satisfactory results without aggravation 
of the disease activity or other complications.
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Cutaneous Dermatomyositis Treated with Intense Pulsed Light Therapy
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InTroDuCTIon 
Dermatomyositis (DM) is an idiopathic inflammatory 
myopathy characterized by typical cutaneous lesions, in-
cluding Gottron’s papules, periorbital violaceous or helio-
trope rash, periungal telangiectasia, facial erythema and 
poikiloderma vasculare atrophicans.1 For the treatment 
of theses cutaneous lesions, topical steroids and topical 
calcineurin inhibitors are commonly used, while systemic 
agents such as glucocorticoids, antimalarials and metho-
trexate may be used in refractory cases.2 Despite all these 
treatments, cutaneous lesions may persist, causing se-
vere impacts on patient’s quality of life. To our knowledge, 
this is the first report of intense pulsed light (IPL) used in 
A B
Fig. 1. Persistent erythema and 
hyperpigmentation is seen on the 
patient’s forehead (A) and her right 
cheek (B).
Fig. 2. Improvement of the skin 
lesions can be observed 6 months 
after the initial intense pulsed light 
(IPL) treatment. 5 sessions of IPL 
treatments have been done.
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the treatment of the persistent facial erythema in cutane-
ous dermatomyositis.
CasE rEPorT
A 48-year-old female visited with skin lesions on her 
forehead, both cheeks, and hands. She was diagnosed 
with dermatomyositis 12 months prior to her visit to the 
dermatology clinic. Typical Gottron’s papules were ob-
served on her dorsums of both hands with persistent ery-
thema and postinflammatory hyperpigmentation on her 
forehead, cheeks, and neck (Fig. 1). Her general symp-
toms were well-controlled with hydroxychloroquine, aza-
thioprine, and low dose systemic steroid. Topical tacroli-
mus was also prescribed, but her cutaneous symptoms 
showed only minimal improvements. She was distressed 
with the redness on her face, which significantly affected 
her quality of life.
Treatment with IPL (BBL; Sciton Inc., CA, USA) was 
tried using 590-nm cutoff filter at a fluence 18-20 J/cm2. 
Double pulse mode (two stacked 5-ms pulses with a 
20-ms delay) was selected. Significant improvements 
were observed with consecutive treatments and after six 
months, with a total five sessions of treatments, the pa-
tient was well-satisfied with the progresses (Fig. 2). The 
patient complained of only mild irritations after the treat-
ments with no aggravation of the disease activity or any 
other severe complications were observed.
DIsCussIon
Due to the disfiguring skin changes in connective tissue 
diseases, the implications of laser therapies have been 
emerging.3 Table 1 lists the reports of the use of lasers in 
dermatomyositis. They have shown that pulsed dye laser 
and argon laser are efficacious in the treatment of ery-
thema, poikiloderma, telangiectasia, and Gottron’s pap-
ules in dermatomyositis.4-6 Although the use of IPL has 
not been applied to cutaneous dermatomyositis, it was 
reported to be effective in treating persistent erythema in 
lupus erythematosus.7 
IPL emits high-intensity polychromatic light in a broad 
wavelength spectrum of 515-1,200 nm. Due to its wide 
spectrum, individual treatment parameters can be se-
lected, adapting to different skin types and indications. 
Because of these characteristics of IPL, its use is indi-
cated in the treatment of various skin lesions, including 
pigmented lesions, erythema, telangiectasia, and hair 
removal,8,9 and its uses are becoming more diverse. 
Regarding safety issue, there have been concerns Ta
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about paradoxical worsening of lesions after exposure to 
lasers or light devices in these photosensitive disorders. 
However, a recent comprehensive review suggested no 
case reports have been published reporting the develop-
ment or worsening of preexisting connective tissue dis-
ease after using lasers.3 
To our best knowledge, this is the first report of the use 
of IPL in a patient with cutaneous dermatomyositis. IPL 
was found to an effective treatment method that did not 
interfere with the disease activity of dermatomyositis. Al-
though more studies on its efficacy are required, IPL can 
be an effective and safe method of treatment for disfigur-
ing skin changes in patients with dermatomyositis.
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